Heritage Wealth Management (Arizona)’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM
Heritage Wealth Management (Arizona)'s ALXN Position: Q3 2021 in Review
Heritage Wealth Management (Arizona) sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 15 shares — an estimated $3K sold.
Heritage Wealth Management (Arizona) first reported a position in ALXN in Q1 2021 and held it in 2 quarters. The position peaked at $9K in Q1 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.
- Heritage Wealth Management (Arizona) reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
- Heritage Wealth Management (Arizona) sold 15 Alexion Pharmaceuticals shares in Q3 2021, an estimated $3K.
- Heritage Wealth Management (Arizona) first reported a position in Alexion Pharmaceuticals in Q1 2021 and held it in 2 quarters.
- Heritage Wealth Management (Arizona)'s Alexion Pharmaceuticals position peaked at $9K in Q1 2021.
- 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.
Based on Heritage Wealth Management (Arizona)'s 13F filing for Q3 2021, filed 10 Nov 2021.